Recent Updates
Recently added Catalysts
ZLAB Positive Sentiment

Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024

Key Takeaway: Zai Lab Limited will report its first quarter 2024 financial results on May 8, 2024, after market close. A conference call and webcast will follow on May 9, 2024, at 8:00 a.m. ET. Participants must register in advance to access the call, which will also be available for replay on the company's website.
Price reaction · baseline $17.96 (2024-05-29 close) · hit pre-market · 13 other ZLAB headline(s) in the window, move may be shared
day 0 close · peak
+1.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Zai Lab is set to announce its first quarter 2024 financial results.
  • The company is actively engaging with investors through a conference call.
  • Zai Lab continues to focus on innovative biopharmaceutical products.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+104%
120-day peak, hindsight
Typical move
8.5%
average across 4 past catalysts
Cash runway
~164 mo
Low dilution risk
Lead asset
ZL-1211
Phase 1 · Advanced Solid Tumor

Full Press Release Details

• Company to Host Conference Call and Webcast on May 9, 2024, at 8:00 a.m. ET (8:00 p.m. HKT) SHANGHAI & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Apr. 15, 2024– Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report financial results for the first quarter of 2024 and recent corporate updates, after the closing of the U.S. equity markets on Wednesday, May 8, 2024. The Company will host a live conference call and webcast on Thursday, May 9, 2024, at 8:00 a.m. ET (8:00 p.m. HKT).
Conference Call and Webcast Information
Listeners may access the live webcast by visiting the Company’s website at http://ir.zailaboratory.com. Participants must register in advance of the conference call.
Details are as follows:
All participants must use the link provided above to complete the online registration process in advance of the conference call. Dial-in details will be in the confirmation email which the participant will receive upon registering.
A replay will be available shortly after the call and can be accessed by visiting the Company’s website.
About Zai Lab
Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in the areas of oncology, autoimmune disorders, infectious disease, and neuroscience. Our goal is to leverage our competencies and resources to positively impact human health in China and worldwide.
For additional information about Zai Lab, including our products, business activities and partnerships, research, and other events or developments, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240411386057/en/
Investor Relations: Christine Chiou / Lina Zhang+1 (917) 886-6929 / +86 136 8257 6943 christine.chiou1@zailaboratory.com / lina.zhang@zailaboratory.com
Media: Shaun Maccoun / Xiaoyu Chen+1 (415) 317-7255 / +86 185 0015 5011 shaun.maccoun@zailaboratory.com / xiaoyu.chen@zailaboratory.com
Source: Zai Lab Limited

Frequently Asked Questions

When will Zai Lab announce its Q1 2024 financial results?

Zai Lab will announce its Q1 2024 financial results on May 8, 2024.

What time is the conference call for Zai Lab's results?

The conference call will be held on May 9, 2024, at 8:00 a.m. ET.

How can I access the Zai Lab conference call?

Participants must register in advance to access the conference call.

Where can I find more information about Zai Lab?

More information can be found on Zai Lab's official website.

Last updated: May 30, 2024